Health Care & Life Sciences » Pharmaceuticals | Shenzhen Salubris Pharmaceuticals Co. Ltd.

Shenzhen Salubris Pharmaceuticals Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
833
1,043
1,270
1,390
1,437
1,455
Depreciation, Depletion & Amortization
56
66
83
122
138
181
Other Funds
-
2
67
428
413
8
Funds from Operations
881
1,079
1,371
1,526
1,552
1,642
Changes in Working Capital
212
80
302
91
76
272
Net Operating Cash Flow
669
999
1,069
1,435
1,476
1,371
Capital Expenditures
427
201
236
245
305
Sale of Fixed Assets & Businesses
-
-
-
-
1
Purchase/Sale of Investments
200
46
191
286
890
Net Investing Cash Flow
627
449
459
530
1,194
Cash Dividends Paid - Total
305
392
392
628
732
Issuance/Reduction of Debt, Net
-
-
-
-
15
Net Financing Cash Flow
305
392
459
200
1,160
Net Change in Cash
265
157
154
708
885
Free Cash Flow
241
798
833
1,190
1,171
Deferred Taxes & Investment Tax Credit
18
33
13
9
6
1
Net Assets from Acquisitions
-
203
414
-
-
Exchange Rate Effect
-
1
3
4
6

About Shenzhen Salubris Pharmaceuticals Co.

View Profile
Address
37/F, Chegongmiao Lujing Plaza Bldg
Shenzhen Guangdong 518040
China
Employees -
Website http://www.salubris.cn
Updated 07/08/2019
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and biomedical products. It offers cardiovascular drugs and antibiotics, and active pharmaceutical ingredient products. The company was founded on November 3, 1998 and is headquartered in Shenzhen, China.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.